Adjunctive raloxifene improves cognition in schizophrenia

The selective estrogen receptor modulator raloxifene significantly improved memory and attention/processing speed relative to placebo in a 13‐week crossover trial that included both men and women with schizophrenia. Raloxifene did not result in a reduction in symptom severity, however.
Source: The Brown University Psychopharmacology Update - Category: Psychiatry Tags: What's New in Research Source Type: research